Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Xtant Medical Holdings, Inc. (XTNT : AMEX)
 
 • Company Description   
Xtant Medical Holdings, Inc. develops, manufactures and markets biologics products. The Company's product used in an applications which includes enhancing fusion in spine surgery, relief of back pain, promotion of bone growth in foot and ankle surgery, promotion of cranial healing following neurosurgery and subchondral repair in knee and other joint surgeries. Xtant Medical Holdings, Inc., formerly known as Bacterin International Holdings, Inc., is based in Belgrade, United States.

Number of Employees: 118

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.54 Daily Weekly Monthly
20 Day Moving Average: 24,940 shares
Shares Outstanding: 87.31 (millions)
Market Capitalization: $47.15 (millions)
Beta: 1.10
52 Week High: $2.38
52 Week Low: $0.48
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -17.62% -7.22%
12 Week -19.40% -11.40%
Year To Date -3.57% 22.23%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
664 CRUISER LANE
-
BELGRADE,MT 59714
USA
ph: 406-388-0480
fax: 406-388-1354
investorrelations@xtantmedical.com http://www.xtantmedical.com
 
 • General Corporate Information   
Officers
Sean E. Browne - Chief Executive Officer;President and Director
Jeffrey Peters - Chairman of the Board and Director
Scott C. Neils - Interim Chief Financial Officer
John Bakewell - Director
Michael Eggenberg - Director

Peer Information
Xtant Medical Holdings, Inc. (ABMD)
Xtant Medical Holdings, Inc. (DMDS)
Xtant Medical Holdings, Inc. (CPWY.)
Xtant Medical Holdings, Inc. (EQUR)
Xtant Medical Holdings, Inc. (ECIA)
Xtant Medical Holdings, Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 98420P308
SIC: 2836
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/04/22
Share - Related Items
Shares Outstanding: 87.31
Most Recent Split Date: 2.00 (0.08:1)
Beta: 1.10
Market Capitalization: $47.15 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/04/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 1.61
Price/Cash Flow: -
Price / Sales: 0.85
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: 0.00%
Sales Growth
vs. Year Ago Period: 3.32%
vs. Previous Quarter: -7.24%
ROE
03/31/22 - -22.21
12/31/21 - -14.84
09/30/21 - -11.44
ROA
03/31/22 - -12.60
12/31/21 - -8.48
09/30/21 - -6.07
Current Ratio
03/31/22 - 3.81
12/31/21 - 4.00
09/30/21 - 4.38
Quick Ratio
03/31/22 - 2.27
12/31/21 - 2.38
09/30/21 - 2.49
Operating Margin
03/31/22 - -12.63
12/31/21 - -8.78
09/30/21 - -5.92
Net Margin
03/31/22 - -12.63
12/31/21 - -8.78
09/30/21 - -5.92
Pre-Tax Margin
03/31/22 - -12.63
12/31/21 - -8.77
09/30/21 - -5.33
Book Value
03/31/22 - 0.34
12/31/21 - 0.36
09/30/21 - 0.38
Inventory Turnover
03/31/22 - 1.25
12/31/21 - 1.13
09/30/21 - 1.03
Debt-to-Equity
03/31/22 - 0.41
12/31/21 - 0.39
09/30/21 - 0.36
Debt-to-Capital
03/31/22 - 28.96
12/31/21 - 27.80
09/30/21 - 26.54
 

Powered by Zacks Investment Research ©